Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
234.8 CHF
3.21%
Market Closed
Updated:
May 16, 2024
Roche Holding AG
Total Equity
|
Roche Holding AG
Total Equity Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Total Equity
CHf29.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Novartis AG
SIX:NOVN
|
Total Equity
$39.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Total Equity
$3.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Total Equity
$8.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Total Equity?
Total Equity
29.3B
CHF
29.3B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Total Equity amounts to 29.3B CHF.
What is Roche Holding AG's Total Equity growth rate?
Total Equity CAGR 10Y
4%
4%
Over the last year, the Total Equity growth was 5%. The average annual Total Equity growth rates for Roche Holding AG have been -7% over the past three years , 1% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
